Clinical Trial Update: A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase II trial update for PM01183 in BRCA1/2-associated or unselected metastatic breast cancer; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PM01183 (PM01183)

Snippet

Sponsor: PharmaMar | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-09-25